- Home
- MNKD vs REVG Comparison
MNKD vs REVG Comparison
Compare MNKD & REVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- REVG
- Stock Information
- Founded
- MNKD 1991
- REVG 2008
- Country
- MNKD United States
- REVG United States
- Employees
- MNKD N/A
- REVG N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- REVG Auto Manufacturing
- Sector
- MNKD Health Care
- REVG Consumer Discretionary
- Exchange
- MNKD Nasdaq
- REVG Nasdaq
- Market Cap
- MNKD 1.5B
- REVG 1.8B
- IPO Year
- MNKD 2004
- REVG 2017
- Fundamental
- Price
- MNKD $5.76
- REVG $31.35
- Analyst Decision
- MNKD Buy
- REVG Hold
- Analyst Count
- MNKD 6
- REVG 4
- Target Price
- MNKD $8.92
- REVG $33.75
- AVG Volume (30 Days)
- MNKD 1.7M
- REVG 500.6K
- Earning Date
- MNKD 02-26-2025
- REVG 03-05-2025
- Dividend Yield
- MNKD N/A
- REVG 0.76%
- EPS Growth
- MNKD N/A
- REVG 512.99
- EPS
- MNKD 0.08
- REVG 4.72
- Revenue
- MNKD $267,200,000.00
- REVG $2,380,200,000.00
- Revenue This Year
- MNKD $44.15
- REVG $0.75
- Revenue Next Year
- MNKD $19.65
- REVG $6.92
- P/E Ratio
- MNKD $72.34
- REVG $6.66
- Revenue Growth
- MNKD 51.35
- REVG N/A
- 52 Week Low
- MNKD $3.47
- REVG $17.76
- 52 Week High
- MNKD $7.63
- REVG $36.00
- Technical
- Relative Strength Index (RSI)
- MNKD 48.03
- REVG 39.33
- Support Level
- MNKD $5.32
- REVG $32.01
- Resistance Level
- MNKD $5.65
- REVG $34.27
- Average True Range (ATR)
- MNKD 0.18
- REVG 1.24
- MACD
- MNKD 0.03
- REVG -0.25
- Stochastic Oscillator
- MNKD 81.48
- REVG 8.73
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About REVG REV Group Inc.
REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. During the first fiscal quarter of 2024, the Company formed the Specialty Vehicles Segment by combining the Fire & Emergency and Commercial segment businesses. Additionally, the Recreation segment was renamed Recreational Vehicles. As a result, the Company is now organized into two reportable segments. The company operates in the United States, Canada, and the rest of the world. Maximum of revenue is gained from Specialty Vehicles Segment.